DR. STEVEN M DUFFY MD NPI 1154586188

NPI Information

  • NPI: 1154586188
  • Provider Name: DR. STEVEN M DUFFY, MD
  • Classification:
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5008 BRITTONFIELD PKWY STE 700
    EAST SYRACUSE, NY
    ZIP 13057
  • Phone: (315) 472-7504

Map and Directions

Get Directions

NPI Details

DR. Steven M Duffy, MD is a healthcare provider in East Syracuse, NY. DR. Steven M Duffy, MD NPI is 1154586188. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

5008 BRITTONFIELD PKWY STE 700
EAST SYRACUSE, NY
ZIP 13057-249
Phone: (315) 472-7504
Fax: (315) 634-4677

The NPI 1154586188 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
  • Injection, atezolizumab, 10 mg (HCPCS:J9022)
  • Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Injection, etoposide, 10 mg (HCPCS:J9181)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, irinotecan, 20 mg (HCPCS:J9206)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Protein measurement, serum (HCPCS:84165)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Magnesium level (HCPCS:83735)
  • Phosphate level (HCPCS:84100)
  • Folic acid level, serum (HCPCS:82746)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)

The enumeration date for this NPI number is 7/18/2008 and was last updated on 10/12/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine251381NEW YORKNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.